Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/108563

In Collections

This item can be found in the following collections:

Asghar, M.S.; Hansen, A.E.; Amin, F.M.; Geest, R.J. van der; Koning, P. van der; Larsson, H.B.W.; ... ; Ashina, M. (2011)

Evidence for a Vascular Factor in Migraine

Article / Letter to editor
Objective: It has been suggested that migraine is caused by neural dysfunction without involvement of vasodilatation. Because dismissal of vascular mechanisms seemed premature, we examined diameter of extra-and intracranial vessels in migraine without aura patients. Methods: A novel high-resolution direct magnetic resonance angiography imaging technique was used to measure arterial circumference of the extracranial middle meningeal artery (MMA) and the intracranial middle cerebral artery (MCA). Data were obtained at baseline, during migraine attack, and after treatment with the migraine abortive drug sumatriptan (a 5-hydroxytryptamine agonist). Results: We found dilatation of both MMA and MCA during migraine attack (p = 0.001). Sumatriptan administration caused amelioration of headache (p < 0.001) and contraction of MMA (p < 0.001), but MCA remained unchanged (p = 0.16). Exploratory analysis revealed that in migraine attacks with half-sided headache, there was only dilatation on the...Show moreObjective: It has been suggested that migraine is caused by neural dysfunction without involvement of vasodilatation. Because dismissal of vascular mechanisms seemed premature, we examined diameter of extra-and intracranial vessels in migraine without aura patients. Methods: A novel high-resolution direct magnetic resonance angiography imaging technique was used to measure arterial circumference of the extracranial middle meningeal artery (MMA) and the intracranial middle cerebral artery (MCA). Data were obtained at baseline, during migraine attack, and after treatment with the migraine abortive drug sumatriptan (a 5-hydroxytryptamine agonist). Results: We found dilatation of both MMA and MCA during migraine attack (p = 0.001). Sumatriptan administration caused amelioration of headache (p < 0.001) and contraction of MMA (p < 0.001), but MCA remained unchanged (p = 0.16). Exploratory analysis revealed that in migraine attacks with half-sided headache, there was only dilatation on the headache side of MMA of 12.49% (95% confidence interval [CI], 4.16-20.83%) and of MCA of 12.88% (95% CI, 3.49-22.27%) and no dilatation on the nonheadache side of MMA (95% CI, -4.27 to 11.53%) and MCA (95% CI, -6.7 to 14.28%). In double-sided headache we found bilateral vasodilatation of both MMA and MCA (p < 0.001). Interpretation: These data show that migraine without aura is associated with dilatation of extra-and intracerebral arteries and that the headache location is associated with the location of the vasodilatation. Furthermore, contraction of extracerebral and not intracerebral arteries is associated with amelioration of headache. Collectively, these data suggest that vasodilatation and perivascular release of vasoactive substances is an integral mechanism of migraine pathophysiology. ANN NEUROL 2011; 69: 635-645Show less
gene-related peptide cortical spreading depression brain-stem activation cerebral-blood-flow neurogenic inflammation unilateral migraine artery dilatation headache sumatriptan attacks
All authors
Asghar, M.S.; Hansen, A.E.; Amin, F.M.; Geest, R.J. van der; Koning, P. van der; Larsson, H.B.W.; Olesen, J.; Ashina, M.
Date
2011-04-30
Volume
69
Issue
4
Pages
635 - 645
DOI
doi:10.1002/ana.22292